G1 Therapeutics, Inc. - stock earnings
GTHX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -10.9 million USD | 14.9 million USD |
| 2023Q3 | -18.2 million USD | 12.3 million USD |
| 2023Q2 | 8.7 million USD | 42.4 million USD |
| 2023Q1 | -32.5 million USD | 12.9 million USD |
| 2022Q4 | -33.6 million USD | 10.3 million USD |
| 2022Q3 | -25.3 million USD | 23.6 million USD |
| 2022Q2 | -41.9 million USD | 10.6 million USD |
| 2022Q1 | -51.6 million USD | 6.9 million USD |
| 2021Q4 | -40.0 million USD | 5.8 million USD |
| 2021Q3 | -42.5 million USD | 4.9 million USD |
| 2021Q2 | -39.4 million USD | 6.6 million USD |
| 2021Q1 | -26.4 million USD | 14.2 million USD |
| 2020Q4 | -25.3 million USD | 16.5 million USD |
| 2020Q3 | -11.7 million USD | 26.6 million USD |
| 2020Q2 | -31.2 million USD | 2.1 million USD |
| 2020Q1 | -31.0 million USD | ? USD |
| 2019Q4 | -35.4 million USD | ? USD |
| 2019Q3 | -32.4 million USD | ? USD |
| 2019Q2 | -30.7 million USD | ? USD |
| 2019Q1 | -24.0 million USD | ? USD |
| 2018Q4 | -24.1 million USD | ? USD |
| 2018Q3 | -19.9 million USD | ? USD |
| 2018Q2 | -20.9 million USD | ? USD |
| 2018Q1 | -20.4 million USD | ? USD |
| 2017Q4 | -17.0 million USD | ? USD |
| 2017Q3 | -15.6 million USD | ? USD |
| 2017Q2 | -15.2 million USD | ? USD |
| 2017Q1 | -12.3 million USD | ? USD |
| 2016Q4 | -10.4 million USD | ? USD |
| 2016Q3 | -6.6 million USD | ? USD |
| 2016Q2 | -7.4 million USD | ? USD |
| 2016Q1 | -6.0 million USD | ? USD |
| 2015Q4 | -20.3 million USD | 522000 USD |
GTHX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -48.0 million USD | 82.5 million USD |
| 2022 | -147.6 million USD | 51.3 million USD |
| 2021 | -148.4 million USD | 31.5 million USD |
| 2020 | -99.3 million USD | 45.3 million USD |
| 2019 | -122.1 million USD | 2.1 million USD |
| 2018 | -85.3 million USD | ? USD |
| 2017 | -60.1 million USD | ? USD |
| 2016 | -30.3 million USD | ? USD |
| 2015 | -20.3 million USD | 522000 USD |
| 2014 | -7.2 million USD | 1.0 million USD |
GTHX
Price: $3.99
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -1.68
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 586179
Ebitda: -15.9 millionMarket Capitalization: 225.0 million